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93.5±33.6 mg/dl, p<0.05), and insulin sensitivity (3.3±1.7 vs. 5.4±1.6 µU x 10-4 · min-1 ·
ml-1, p<0.0001) following weight loss. Brachial artery compliance (p<0.05) and distensi-
bility (p<0.05) curves over the physiological pressure range improved (figure), whereas
endothelial function and intima-media thickness remained unchanged. Conclusions: In
overweight adults, six months of weight loss resulted in improvements in body composi-
tion, insulin sensitivity, lipid profile, and brachial artery compliance and distensibility.
9:45 a.m.
865-6 Nitric Oxide Synthase Gene Polymorphism (G894T) 
Influences Arterial Stiffness in Adults: The Bogalusa 
Heart Study
Wei Chen, Sathanur R. Srinivasan, M. Gene Bond, Rong Tang, Elaine M. Urbina, 
Shengxu Li, Eric Boerwinkle, Gerald S. Berenson, Tulane University Health Sciences 
Center, New Orleans, LA, University of Texas-Houston Health Science Center, Houston, 
TX
Background: The endothelial nitric oxide synthase (eNOS) gene is known to influence
the regulation of blood pressure levels. However, whether the eNOS gene locus influ-
ences arterial stiffness, independently of blood pressure, is unknown.
Methods: Arterial stiffness was measured in 118 black and 285 white young adults aged
25-37 years from M-mode ultrasounds of common carotid artery using Peterson’s (Ep)
and Young’s (YEM) elastic modulus.
Results: Blacks displayed a lower frequency of the T allele than whites (0.131 vs 0.321,
P<0.001). The T allele was associated with lower systolic blood pressure in blacks
(P=0.04), but not in whites. Blacks showed significantly higher values of Ep (i.e.
increased stiffness) than whites (49.9 kPa vs 45.5 kPa, P=0.003); whereas no such race
difference was found for YEM, a measure of elasticity adjusted for relative wall thickness.
After controlling for sex, age, BMI and mean arterial pressure, the T allele was associ-
ated with significantly lower values of Ep (P=0.012) and YEM (P=0.034) in blacks.
Although similar trends were seen in whites, the genotype effect on Ep and YEM was not
significant. In the total sample, including race as an additional covariate, the G894T gen-
otype was associated with Ep (P=0.051) and YEM (P=0.038).
Conclusion: These results suggest that the G894T polymorphism at the eNOS gene
locus is associated with lower arterial wall stiffness, adjusting for blood pressure levels, in
asymptomatic young adults, especially in blacks.
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867-1 A Functional Role for Inducible Costimulator in 
Atherosclerosis
Jacob George, Gad Keren, Tel Aviv Medical Center, Tel Aviv, Israel
Background: Lymphocytes appear to influence atherosclerosis by altering cytokine pro-
duction. Whereas primary lymphocyte activation requires T cell receptor ligation, costim-
ulatory signals also appear requisite for generation of a functional T cell response.
Inducible costimulator (ICOS) is a newly discovered T cell molecule with a dual role in
immune mediated disorders. Herein, we tested the importance of ICOS in atherosclero-
sis.
Methods and results: Atherosclerotic plaques from humans and ApoE-KO mice were
studied immunohistochemically for the presence and localization of ICOS and its recep-
tors and its expression in splenocytes. ApoE-KO mice were immunized with human
ICOS/Fc-chimera or non-fused Fc and either provided a chow diet for 6 weeks, or a high
fat diet for 8 weeks.
ICOS was abundantly expressed within plaques of humans and ApoE-KO mice and colo-
calized with CD3 cells whereas ICOS ligand was expressed in plaque macrophages.
Spleen cells from atherosclerotic mice exhibited lowered constitutive expression of ICOS
yet priming with oxLDL enhanced ICOS expression dose-dependently.
In mice induced to develop fatty streaks and to generate ICOS blocking antibodies, early
atherosclerosis was increased by ~77% whereas upon inducing more advanced lesions,
the increase in plaque area upon ICOS blockade group was ~36%. IFN-gamma secretion
by oxLDL-primed splenocytes in ICOS-immunized mice increased whereas IL-10 secre-
tion diminished as compared to control animals. A similar trend in cytokine production
was evident in the lesion by immunohistochemistry.
Conclusion: ICOS appears as an influential costimulatory pathway in atherosclerosis that
may play a protective rather that a proatherogenic role.
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867-2 Simvastatin Augments Rac Activation of Akt Signaling 
and Inhibits Endothelial Apoptosis by Modifying 
Subcellular Localization
David Gregg, Neuza H. Lopes, Pascal J. Goldschmidt, Duke University Medical Center, 
Durham, NC
Background: HMG Co-A Reductase inhibitors (statins) inhibit atherosclerosis to a
greater degree than would be predicted by lipid reduction alone.One focus has been on
the ability of statins to block prenylation of the Rho GTPase Rac to inhibit its signaling.
We hypothesized that rather than completely inhibiting Rac signaling, statins selectively
modulate Rac by altering subcellular localization. Methods and Results: To test the
hypothesis that unprenylated cytosolic Rac may activate signaling pathways unique from
cellular membrane localized Rac, we overexpressed a constitutively active RacV12
mutant in human aortic endothelial cells and treated with simvastatin (25µM) or gera-
nylgeranyl transferase inhibitor (GGTI-298 5µM). We found, using fractionation by ultra-
centrifugation and immunofluorescence, both inhibitors of prenylation altered subcellular
localization, shifting RacV12 from 59% membrane localized to 2% and 4.1% with simvas-
tatin and GGTI respectively. Prenylation inhibition had minimal effect on “Rac activity”
determined by PAK-PBD affinity precipitation of total lysate and superoxide production
but instead strongly shifted activity from the membrane to the cytoplasmic fraction.
Untreated Rac V12 activated AKT, but simvastatin and GGTI treatment further increased
p-AKT by two fold. Physiologically, this activation was mimicked by a two-fold inhibition of
serum starvation induced apoptosis in Rac V12 cells treated with simvastatin or GGTI
compared to RacV12 alone (Rac V12 25% decrease relative to CT, RacV12+simvastatin
62%, RacV12+GGTI 55%). In contrast, simvastatin and GGTI had no effect on apoptosis
in quiescent adenoviral null control cells where there is minimal Rac activity. Conclu-
sions: These data support a novel understanding of Rac signaling, subcellular localiza-
tion, and its modulation by statins that may better explain the pleotropic effects of statins.
Rather than globally inhibiting Rac, prenylation deficient Rac appears to become cytosol-
ically distributed where it remains “active” and has a more potent ability to stimulate
endothelial cell survival through AKT phosphorylation that may enhance plaque stability
and protect from atherosclerosis.
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867-3 Peroxynitrite Inactivates Akt Pathway and Enhances 
Tissue Factor Expression in Thrombin Stimulated 
Endothelial Cells
Maria Berrozpe, Masato Eto, Hana Joch, Csaba Szabó, Thomas Felix Lüscher, 
Cardiovascular Research, Institute of Physiology, University of Zurich, Zurich, 
Switzerland, Inotek Pharmaceuticals Corporation, Beverly, MA
Background: Tissue Factor (TF) plays a pivotal role in thrombus formation in acute coro-
nary syndromes. Peroxynitrite (NOO-) modifies protein activity by nitration of certain
amino acids. However the influence of peroxynitrite in TF expression and activity and the
signaling pathways involved in this phenomena remains unclear. Aim: To elucidate the
effect of NOO- on TF and the role that Akt has in this effect. Methods and Results: Inter-
nal mammary artery endothelial cells were incubated with SIN-1 (NOO- donor), FP15
(NOO- catalyst), TEMPOL ( superoxide scavenger)and wortmmanin (PI3K inhibitor) dur-
ing 1 hour. Afterwards, thrombin was added. Ten minutes after thrombin stimulation Akt
phosphorylation (measured by western blotting) decreased and 5 hours later, TF expres-
sion (measured by western blotting) and activity (Measured by American Diagnostica kit)
increased (Figure A). Wortmannin and SIN-1 potenciated this effect. Not only potencia-
tion of SIN-1 but also thrombin effect was reversed by coincubation with FP15 and TEM-
POL. NOO- staining by DCF demonstrated a significant increase in thrombin stimulated
cells (Figure B, DCF:green, endothelial cell marker CD31: red, nuclei: blue). Conclu-
sions: These data demonstrate an inhibitory effect of NOO- in Akt phosphorilation that
potentiates thrombin induced TF expression and activity in human endothelial cells.
Thus, oxidative stress with formation of NOO- from nitric oxide may be thrombogenic via
this pathway.
